<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="347781">
  <stage>Registered</stage>
  <submitdate>29/11/2011</submitdate>
  <approvaldate>5/12/2011</approvaldate>
  <actrnumber>ACTRN12611001238965</actrnumber>
  <trial_identification>
    <studytitle>suboccipital inhibition technique effectiveness over median neurodynamic test in whiplash patients</studytitle>
    <scientifictitle>suboccipital musculature inhibition technique effectiveness over the elbow extension during median nerve neurodynamic test in whiplash patients</scientifictitle>
    <utrn>U1111-1126-1510</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>whiplash injuries</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>we make a suboccipital musculature inhibition technique trying to relax the myodural brigde, and so measure the impact of this technique on the dural tissue and show it using the median neurodynamic test by measuring the range of elbow.
The suboccipital musculature inhibition technique is performed for a total of 3 minutes, estimated time as sufficient so that there is a relaxation of the muscles. 
This technique only is perform once in each patient</interventions>
    <comparator>Placebo.
Hip and knee flexion-extension movement from the measure opposite side.
Given that this movement has no influence on the dural structure, must not cause any change in the median nerve neurodynamic test of the subject, so the patient feels that carried out you intervention, thus trying to blind patient.</comparator>
    <control>Placebo</control>
    <interventioncode>Rehabilitation</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in the elbow extension range during the median neurodynamic test</outcome>
      <timepoint>1 minute after the technique</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Change in the patients pain, using the scale visual analog.</outcome>
      <timepoint>1 minute after the technique</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Changes in the patients hand strengh. To perform this measurement use a dynamometer of hand grip</outcome>
      <timepoint>1 minute after the technique</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patient who suffered whiplash injuries grade I or II 
median neurodynamic test positve</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>55</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>suboccipital technique contraindications
Patient with cervical pain in the last 3 month
Patient with whiplash grade III or IV</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>envelopes with a number in its interior, assigning the 1 for intervention the 2 for the control</concealment>
    <sequence>The envelopes are interleaved and the patient chooses one.
Given that I only need 40 patients (20 for the intervention group and 20 for the control group), is it is a way forward which I think is fair and out given that each patient has an equal chance to go to one group or another and at the same time maintaining the balance in the number of patients allocated to each group.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>12/12/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Spain</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Pedro Jose Antolinos Campillo</primarysponsorname>
    <primarysponsoraddress>Calle Lanzarote, 25, San Javier (Murcia) 30730</primarysponsoraddress>
    <primarysponsorcountry>Spain</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Pedro Jose Antolinos Campillo</fundingname>
      <fundingaddress>Calle Lanzarote, 25, San Javier (Murcia) 30730</fundingaddress>
      <fundingcountry>Spain</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Antonio Francisco Martinez Franco</othercollaboratorname>
      <othercollaboratoraddress>C/ Ronda Norte, 21, 3 C
30009, Murcia.</othercollaboratoraddress>
      <othercollaboratorcountry>Spain</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Angel Oliva Pascual-Vaca</othercollaboratorname>
      <othercollaboratoraddress>C/ Goleta 6
41740 Lebrija (Sevilla)</othercollaboratoraddress>
      <othercollaboratorcountry>Spain</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Cleofas Rodriguez Blanco</othercollaboratorname>
      <othercollaboratoraddress>C/ Otono 35
41710 Utrera (Sevilla)</othercollaboratoraddress>
      <othercollaboratorcountry>Spain</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study aims to determine the efficiency of the suboctipital musculature inhibition technique in the median nerve neurodynamic test in patients with whiplash.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Comite etico de Experimentacion de la Universidad de Sevilla</ethicname>
      <ethicaddress>Comite de etica. Pabellon de Brasil. Universidad de Sevilla. Paseo de las Delicias s/n 41013 Sevilla.</ethicaddress>
      <ethicapprovaldate>5/11/2011</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Spain</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Pedro Jose Antolinos Campillo</name>
      <address>C/ Lanzarote, 25, San Javier (Murcia) CP 30730</address>
      <phone>666262728</phone>
      <fax />
      <email>pj_antolinos@hotmail.com</email>
      <country>Spain</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Pedro Jose Antolinos Campillo</name>
      <address>C/ Lanzarote, 25, San Javier (Murcia) CP 30730</address>
      <phone>666262728</phone>
      <fax />
      <email>pj_antolinos@hotmail.com</email>
      <country>Spain</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>